Review Article

Potential Role of Antioxidants as Adjunctive Therapy in Chagas Disease

Table 1

Evidence supporting antioxidant use in Chagas disease as revealed by research in animal models.

Reference #Author, yearExperimental modelAge in weeksT. cruzi strain (trypomastigotes challenge dose)TreatmentAntioxidant/oxidative stress markersTissue samples

[94]Horta et al., 2018C57BL/6 male mice8-10Colombian (50) benznidazole for 23 days by gavageSOD and CAT activity, TBARS, protein carbonylsHeart
[52]Castanheira et al., 2018Swiss SWR/J male mice3.5QM2 (5 × 104)500 mg/day vitamin C for 60 days in drinking waterFRAP, GSH, GST, plasma sulfhydryl (SH) group, nitrate/nitritePlasma, heart, colon, skeletal muscle
[58]Providello et al., 2018Swiss SWR/J male mice6Y (1 × 104) benznidazole for 15 days by gavageTBARS ROSHeart, macrophages
[56]Contreras-Ortiz et al., 2017BALB/c female mice4-6Ninoa (10) nifurtimox for 60 days orallyMDAHeart, spleen, blood
[90]Montenote et al., 2017Swiss SWR/J male mice3QM2 (5 × 104)20% blackberry plant extract (25-75 μl/day) 180 days orallyTBARS, FRAP, GSH, and sulfhydryl groupsPlasma
[53]Tieghi et al., 2017Swiss SWR/J male mice3QM2 (5 × 104)500 mg/day vitamin C and 800 IU/day vitamin E (individually and in combination) for 60 days or 120 daysFRAP, GSH, TBARSPlasma, heart, colon, and skeletal muscle
[48]Novaes et al., 2017Swiss SWR/J male mice52Y (2 × 103)500 mg/day vitamin C/800 UI/day vitamin E for 15 days orallyTBARS, PCN, catalase, GST and SOD activities, nitrite/nitrate, 8-OHdGHeart
[69]Vilar-Pereira et al., 2016BALB/c male & female mice5-7Colombian (2 × 102)15 mg/kg trans-resveratrol (i.p.) or 40 mg/kg resveratrol, 500 mg/kg metformin, 100 mg/kg/Tempol, or 25 mg/kg benznidazole for 30 days (per orally)TBARSHeart
[55]Novaes et al., 2016SWR/J female mice8-12Y (2 × 103) for 20 days by gavage, C100 (±B50-B100), B50-B100 only (mg/kg/day)MDA and PCNHeart, liver
[54]Brazao et al., 2015Wistar male ratsNRY (1 × 105)5 mg/kg melatonin/day for 60 days orallyNitrite production in macrophages; TBARS in plasmaPlasma, spleen
[60]Marim et al., 2015SWR/J male mice3QM1 (5 × 104)10 μl vitamin C (D60 mg or D500 mg) per day for 60 days or 180 days orallyTBARS, total peroxide, GSHPlasma, heart, colon, skeletal muscle
[84]Nagajyothi et al., 2012CD1 mice6-8Brazil (5 × 104)100 mg/kg/day curcumin for 35 days orallymRNA levels of enzymes/proteinsHeart
[64]Wen and Garg, 2012Sprague Dawley rats4–5Sylvio ×10 (5 × 104)1.3 mM PBN and/or 0.7 mM benznidazole for three weeks in drinking waterPCNHeart, heart mitochondria
[51]Wen et al., 2010Sprague Dawley rats4–5Sylvio ×10 (5 × 104)1.3 mM PBN and/or 0.7 mM benznidazole for three weeks in drinking waterROS, TBARSHeart, heart mitochondria
[89]Francisco et al., 2010SWR/J male mice4Y (5 × 102)5 mg/50 μl/day desferrioxamine (i.p.) 14 days prior to infection and for 21 days i.p.GSH, TBARS, PCN, nitrate/nitriteSerum, liver
[50]Wen et al., 2006C57BL/6 mice6-8Sylvio ×10 (1 × 104)50 mg/kg PBN (i.p.) on alternate days for three weeksRespiratory complex activities, MDA, GSH, ATP, H2O2Heart, heart mitochondria

Cv: carvedilol; SOD: superoxide dismutase; CAT: catalase; MDA: malondialdehyde; GSH: glutathione; GST: glutathione S-transferase; FRAP: plasma antioxidant capacity; TBARS: thiobarbituric acid reactive substances; PCN: protein carbonyl levels; PBN: phenyl-alfa-tert-butyl nitrone; B100: 100 mg/kg of body weight benznidazole; B50: 50 mg/kg benznidazole; C100: 100 mg/kg curcumin; dpi: days postinfection.